$NEOG
NEOGEN CORP

2023 Q2 Form 10-K Financial Statement

#000095017023042861 Filed on August 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 2022
Revenue $241.8M $822.4M $527.2M
YoY Change 72.61% 56.01% 12.53%
Cost Of Revenue $118.6M $416.5M $284.1M
YoY Change 57.97% 46.58% 12.13%
Gross Profit $123.2M $406.0M $243.0M
YoY Change 89.51% 67.05% 13.0%
Gross Profit Margin 50.94% 49.36% 46.1%
Selling, General & Admin $92.70M $342.4M $167.3M
YoY Change 114.88% 104.61% 34.26%
% of Gross Profit 75.26% 84.34% 68.86%
Research & Development $7.054M $26.04M $17.05M
YoY Change 84.13% 52.73% 4.94%
% of Gross Profit 5.73% 6.41% 7.02%
Depreciation & Amortization $28.44M $88.38M $23.69M
YoY Change 385.22% 272.99% 12.61%
% of Gross Profit 23.09% 21.77% 9.75%
Operating Expenses $99.76M $368.4M $184.4M
YoY Change 112.38% 99.81% 30.88%
Operating Profit $23.43M $37.52M $58.62M
YoY Change 29.94% -36.0% -20.97%
Interest Expense -$15.99M $27.25M $1.267M
YoY Change -2536.89% 2051.07% -21.5%
% of Operating Profit -68.24% 72.65% 2.16%
Other Income/Expense, Net -$15.78M -$59.56M $1.589M
YoY Change -7080.09% -3848.08% 44.59%
Pretax Income $7.650M -$22.04M $60.21M
YoY Change -59.54% -136.61% -20.01%
Income Tax $2.078M $828.0K $11.90M
% Of Pretax Income 27.16% 19.77%
Net Earnings $5.572M -$22.87M $48.31M
YoY Change -62.75% -147.34% -20.65%
Net Earnings / Revenue 2.3% -2.78% 9.16%
Basic Earnings Per Share -$0.12 $0.45
Diluted Earnings Per Share $0.03 -$0.12 $0.45
COMMON SHARES
Basic Shares Outstanding 216.3M 188.9M 107.7M
Diluted Shares Outstanding 188.9M 108.0M

Balance Sheet

Concept 2023 Q2 2023 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $245.6M $245.6M $381.1M
YoY Change -35.55% -35.55% -0.01%
Cash & Equivalents $245.6M $245.6M $44.47M
Short-Term Investments $82.33M $82.33M $336.6M
Other Short-Term Assets $53.30M $53.30M $23.76M
YoY Change 124.31% 124.31% 33.18%
Inventory $133.8M $133.8M $122.3M
Prepaid Expenses
Receivables $153.3M $153.3M $99.67M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $585.9M $585.9M $626.8M
YoY Change -6.52% -6.52% 5.98%
LONG-TERM ASSETS
Property, Plant & Equipment $198.7M $198.7M $113.8M
YoY Change 79.73% 74.7% 10.53%
Goodwill $2.137B
YoY Change 1397.85%
Intangibles $1.605B
YoY Change
Long-Term Investments
YoY Change
Other Assets $15.22M $15.22M $2.156M
YoY Change 605.94% 605.94% 6.79%
Total Long-Term Assets $3.969B $3.969B $366.1M
YoY Change 983.9% 983.9% 11.37%
TOTAL ASSETS
Total Short-Term Assets $585.9M $585.9M $626.8M
Total Long-Term Assets $3.969B $3.969B $366.1M
Total Assets $4.554B $4.554B $992.9M
YoY Change 358.69% 358.69% 7.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $76.67M $76.67M $34.61M
YoY Change 121.5% 121.5% 44.83%
Accrued Expenses $57.24M $57.24M $35.64M
YoY Change 60.58% 60.58% 27.98%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $145.5M $145.5M $77.84M
YoY Change 86.88% 86.88% 45.23%
LONG-TERM LIABILITIES
Long-Term Debt $885.4M $885.4M $0.00
YoY Change
Other Long-Term Liabilities $1.275B $1.275B $10.70M
YoY Change 11813.49% 11813.49% 148.9%
Total Long-Term Liabilities $1.275B $1.275B $10.70M
YoY Change 11813.49% 11813.49% 148.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $145.5M $145.5M $77.84M
Total Long-Term Liabilities $1.275B $1.275B $10.70M
Total Liabilities $1.420B $1.420B $105.6M
YoY Change 1245.47% 1245.47% 32.25%
SHAREHOLDERS EQUITY
Retained Earnings $565.0M
YoY Change -3.89%
Common Stock $34.60M
YoY Change 100.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.134B $3.134B $887.4M
YoY Change
Total Liabilities & Shareholders Equity $4.554B $4.554B $992.9M
YoY Change 358.69% 358.69% 7.9%

Cashflow Statement

Concept 2023 Q2 2023 2022
OPERATING ACTIVITIES
Net Income $5.572M -$22.87M $48.31M
YoY Change -62.75% -147.34% -20.65%
Depreciation, Depletion And Amortization $28.44M $88.38M $23.69M
YoY Change 385.22% 272.99% 12.61%
Cash From Operating Activities $90.97M $41.03M $68.04M
YoY Change 346.13% -39.7% -16.09%
INVESTING ACTIVITIES
Capital Expenditures $25.50M $65.76M -$24.43M
YoY Change -303.41% -369.18% -8.55%
Acquisitions -$11.72M $38.75M
YoY Change -130.25% -23.69%
Other Investing Activities $32.38M $266.8M -$72.80M
YoY Change -809.93% -466.48% -7.68%
Cash From Investing Activities $6.876M $201.0M -$97.23M
YoY Change -140.21% -306.77% -7.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $100.0M $0.00
YoY Change
Cash From Financing Activities 252.0K -118.1M 6.813M
YoY Change -124.49% -1833.17% -79.69%
NET CHANGE
Cash From Operating Activities 90.97M 41.03M 68.04M
Cash From Investing Activities 6.876M 201.0M -97.23M
Cash From Financing Activities 252.0K -118.1M 6.813M
Net Change In Cash 98.09M 118.8M -31.13M
YoY Change 4236.6% -481.53% -433.54%
FREE CASH FLOW
Cash From Operating Activities $90.97M $41.03M $68.04M
Capital Expenditures $25.50M $65.76M -$24.43M
Free Cash Flow $65.46M -$24.73M $92.47M
YoY Change 98.8% -126.74% -14.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000711377
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
1.33
CY2019Q2 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OperatingLeaseLiability
CY2022Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrent
CY2023Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrent
CY2022Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q2 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OperatingLeaseLiability
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
CY2023Q2 us-gaap Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration
EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#Liabilities
CY2022Q2 us-gaap Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration
EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#Liabilities
CY2023Q2 us-gaap Environmental Loss Contingency Current Statement Of Financial Position Extensible Enumeration
EnvironmentalLossContingencyCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#LiabilitiesCurrent
CY2023Q2 us-gaap Environmental Loss Contingency Noncurrent Statement Of Financial Position Extensible Enumeration
EnvironmentalLossContingencyNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-05-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
0-17988
CY2023 dei Entity Registrant Name
EntityRegistrantName
NEOGEN CORPORATION
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MI
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
38-2367843
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
620 Lesher Place
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Lansing
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
MI
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
48912
CY2023 dei City Area Code
CityAreaCode
517
CY2023 dei Local Phone Number
LocalPhoneNumber
372-9200
CY2023 dei Security12g Title
Security12gTitle
Common Stock, $0.16 par value per share
CY2023 dei Trading Symbol
TradingSymbol
NEOG
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Public Float
EntityPublicFloat
3572273371
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
216308912
CY2023 dei Auditor Name
AuditorName
BDO USA, P.A.
CY2023 dei Auditor Location
AuditorLocation
Grand Rapids, MI
CY2023 dei Auditor Firm
AuditorFirmId
243
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
163240000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44473000
CY2023Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
82329000
CY2022Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
336578000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
153253000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
99674000
CY2023Q2 us-gaap Inventory Net
InventoryNet
133812000
CY2022Q2 us-gaap Inventory Net
InventoryNet
122313000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
53297000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23760000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
585931000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
626798000
CY2023Q2 us-gaap Land And Land Improvements
LandAndLandImprovements
10209000
CY2022Q2 us-gaap Land And Land Improvements
LandAndLandImprovements
9485000
CY2023Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
96794000
CY2022Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
79513000
CY2023Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
152547000
CY2022Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
114180000
CY2023Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
7080000
CY2022Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
6307000
CY2023Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
52237000
CY2022Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
5974000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
318867000
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
215459000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
120118000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
104875000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
198749000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
110584000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11933000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3184000
CY2023Q2 us-gaap Goodwill
Goodwill
2137496000
CY2022Q2 us-gaap Goodwill
Goodwill
142704000
CY2023Q2 us-gaap Other Indefinite Lived Intangible Assets
OtherIndefiniteLivedIntangibleAssets
14316000
CY2022Q2 us-gaap Other Indefinite Lived Intangible Assets
OtherIndefiniteLivedIntangibleAssets
15397000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1590787000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
92106000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15220000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2156000
CY2023Q2 us-gaap Other Assets
OtherAssets
3769752000
CY2022Q2 us-gaap Other Assets
OtherAssets
255547000
CY2023Q2 us-gaap Assets
Assets
4554432000
CY2022Q2 us-gaap Assets
Assets
992929000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
76669000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
34614000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25153000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11123000
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
6951000
CY2022Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2126000
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
11149000
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4616000
CY2022Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5460000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
20934000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
24521000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
145472000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
77844000
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
353427000
CY2022Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
17011000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
885439000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
35877000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10700000
CY2023Q2 us-gaap Liabilities
Liabilities
1420215000
CY2022Q2 us-gaap Liabilities
Liabilities
105555000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.16
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.16
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
315000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
315000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
216245501
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
216245501
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107801094
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107801094
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
34599000
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
17248000
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2567828000
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
309984000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-33251000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-27769000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
565041000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
587911000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3134217000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
887374000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4554432000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
992929000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
822447000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
527159000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
468459000
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
416492000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
284146000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
253403000
CY2023 us-gaap Gross Profit
GrossProfit
405955000
CY2022 us-gaap Gross Profit
GrossProfit
243013000
CY2021 us-gaap Gross Profit
GrossProfit
215056000
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
141222000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
84604000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
73443000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
201179000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
82742000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51197000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26039000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17049000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16247000
CY2023 us-gaap Operating Expenses
OperatingExpenses
368440000
CY2022 us-gaap Operating Expenses
OperatingExpenses
184395000
CY2021 us-gaap Operating Expenses
OperatingExpenses
140887000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
37515000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
58618000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
74169000
CY2023 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3166000
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1339000
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1692000
CY2023 us-gaap Interest Expense Other
InterestExpenseOther
55961000
CY2022 us-gaap Interest Expense Other
InterestExpenseOther
72000
CY2021 us-gaap Interest Expense Other
InterestExpenseOther
78000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6762000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
322000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-515000
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-59557000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1589000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1099000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22042000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
60207000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
75268000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
828000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11900000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14386000
CY2023 us-gaap Profit Loss
ProfitLoss
-22870000
CY2022 us-gaap Profit Loss
ProfitLoss
48307000
CY2021 us-gaap Profit Loss
ProfitLoss
60882000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.57
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
188881000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107684000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106499000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
188881000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
108020000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107120000
CY2023 us-gaap Profit Loss
ProfitLoss
-22870000
CY2022 us-gaap Profit Loss
ProfitLoss
48307000
CY2021 us-gaap Profit Loss
ProfitLoss
60882000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4796000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-13955000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8602000
CY2023 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
389000
CY2022 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-728000
CY2021 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-80000
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1353000
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2439000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-268000
CY2023 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-644000
CY2023 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-2039000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5482000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-16394000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8334000
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-28352000
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
31913000
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
69216000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
725177000
CY2021 neog Stock Issued During Period Value Exercise Of Options Restricted Stock Units And Share Based Compensation
StockIssuedDuringPeriodValueExerciseOfOptionsRestrictedStockUnitsAndShareBasedCompensation
39680000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1388000
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
4916000
CY2021 us-gaap Profit Loss
ProfitLoss
60882000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8334000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
840377000
CY2022 neog Stock Issued During Period Value Exercise Of Options Restricted Stock Units And Share Based Compensation
StockIssuedDuringPeriodValueExerciseOfOptionsRestrictedStockUnitsAndShareBasedCompensation
13208000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1876000
CY2022 us-gaap Profit Loss
ProfitLoss
48307000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-16394000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
887374000
CY2023 neog Stock Issued During Period Value Exercise Of Options Restricted Stock Units And Share Based Compensation
StockIssuedDuringPeriodValueExerciseOfOptionsRestrictedStockUnitsAndShareBasedCompensation
10496000
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1858000
CY2023 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
2262841000
CY2023 us-gaap Profit Loss
ProfitLoss
-22870000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5482000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3134217000
CY2023 us-gaap Profit Loss
ProfitLoss
-22870000
CY2022 us-gaap Profit Loss
ProfitLoss
48307000
CY2021 us-gaap Profit Loss
ProfitLoss
60882000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
88377000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23694000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21041000
CY2023 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
3109000
CY2022 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2021 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2023 neog Loss On Sale Of Minority Interest And Investment
LossOnSaleOfMinorityInterestAndInvestment
2016000
CY2022 neog Loss On Sale Of Minority Interest And Investment
LossOnSaleOfMinorityInterestAndInvestment
0
CY2021 neog Loss On Sale Of Minority Interest And Investment
LossOnSaleOfMinorityInterestAndInvestment
0
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-19230000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4695000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-640000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
10177000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
7154000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
6437000
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
486000
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2720000
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
53879000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7798000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2595000
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9955000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
21072000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2450000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3121000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4054000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3386000
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
18642000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
20238000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2221000
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
4052000
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-1566000
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-6264000
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
879000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
41028000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
68038000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
81089000
CY2023 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
65757000
CY2022 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
24429000
CY2021 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
26712000
CY2023 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
266772000
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
381839000
CY2021 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
764597000
CY2023 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
12523000
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
415894000
CY2021 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
792678000
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
826000
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-11721000
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
38745000
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
50771000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
201039000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-97229000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-105564000
CY2023 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1195000
CY2022 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
7933000
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
34631000
CY2023 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
19276000
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2023 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
100000000
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
CY2023 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0
CY2022 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1120000
CY2021 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1087000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-118081000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6813000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33544000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-5219000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-8751000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
264000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
118767000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-31129000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9333000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
44473000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75602000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66269000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
163240000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
44473000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75602000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
42616000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
72000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
78000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
15473000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
17242000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
14966000
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
90900000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1129987000
CY2023 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P18Y
CY2023Q2 neog Cash Held By Foreign Subsidiaries
CashHeldByForeignSubsidiaries
36288000
CY2022Q2 neog Cash Held By Foreign Subsidiaries
CashHeldByForeignSubsidiaries
17057000
CY2023Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
82329000
CY2022Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
336578000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
71085000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9600000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7753000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
93200000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
92900000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
92300000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect amounts reflected in the consolidated financial statements. Considerable judgment is often involved in making such estimates, and the use of different assumptions could result in different conclusions. Management believes its assumptions and estimates are reasonable and appropriate. However, actual results could differ from those estimates.</span></p>
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1650000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1400000
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1350000
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1460000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
332000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
239000
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
46000
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
98000
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
139000
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
329000
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
180000
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
328000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2827000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1650000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1400000
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
64971000
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
58667000
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5369000
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6388000
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
63472000
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
57258000
CY2023Q2 us-gaap Inventory Net
InventoryNet
133812000
CY2022Q2 us-gaap Inventory Net
InventoryNet
122313000
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
6270000
CY2022Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4050000
CY2023 us-gaap Depreciation
Depreciation
17292000
CY2022 us-gaap Depreciation
Depreciation
14094000
CY2021 us-gaap Depreciation
Depreciation
13288000
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-22870000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
48307000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
60882000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
188881000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107684000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106499000
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
336000
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
621000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
188881000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
108020000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107120000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.57
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
148000
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
383000
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11933000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3184000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3277000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1440000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8812000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1788000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y8M12D
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.047
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.017
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
2097000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
438000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
460000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
277000
CY2023 us-gaap Lease Cost
LeaseCost
2557000
CY2022 us-gaap Lease Cost
LeaseCost
715000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
2139000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
1407000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
1397000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
11192000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
91700000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3542000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3014000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2725000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1624000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1105000
CY2023Q2 neog Lessee Operating Lease Liability Payments Due Year Six And Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueYearSixAndThereafter
1885000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13895000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1806000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
12089000
CY2023 neog Products And Services Payment Terms
ProductsAndServicesPaymentTerms
30 to 60 days
CY2022Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2023 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
11046000
CY2022 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
10229000
CY2023 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
11890000
CY2022 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
8173000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
822447000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
527159000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
468459000
CY2021Q2 us-gaap Goodwill
Goodwill
131476000
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
15904000
CY2022 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
-4676000
CY2022Q2 us-gaap Goodwill
Goodwill
142704000
CY2023 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1992259000
CY2023 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
2533000
CY2023Q2 us-gaap Goodwill
Goodwill
2137496000
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1714041000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
123254000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1590787000
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
147522000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
55416000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
92106000
CY2022 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P8Y
CY2020Q4 neog Business Combination Consideration Payable
BusinessCombinationConsiderationPayable
8600000
CY2021Q3 neog Maximum Potential Payments
MaximumPotentialPayments
6500000
CY2021Q3 neog Maximum Future Royalty Payments
MaximumFutureRoyaltyPayments
14500000
CY2023Q1 neog Gain On Performance Milestone Liability
GainOnPerformanceMilestoneLiability
300000
CY2022Q3 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
1310000
CY2022Q4 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
37000
CY2022Q3 neog Business Combination Consideration Payable
BusinessCombinationConsiderationPayable
234000
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
620000
CY2023Q1 neog Maximum Potential Payments
MaximumPotentialPayments
8500000
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
930000
CY2023Q2 neog Business Combination Adjustments To Intangible Assets
BusinessCombinationAdjustmentsToIntangibleAssets
3820000
CY2023Q2 neog Business Combination Adjustments To Contingent Liability
BusinessCombinationAdjustmentsToContingentLiability
1070000
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
900000000
CY2023Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
14561000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
885439000
CY2023Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
15000000
CY2023 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2023-11-30
CY2023 us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
LIBOR plus 100 basis points
CY2023Q2 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
1588000
CY2023 us-gaap Interest Expense
InterestExpense
27254000
CY2023 neog Swap Credit
SwapCredit
577000
CY2023 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
10985000
CY2023Q2 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
6683000
CY2023 neog Interest Expenses Related To Amortization Debt Issuance Costs
InterestExpensesRelatedToAmortizationDebtIssuanceCosts
766000
CY2023 us-gaap Interest Expense Debt
InterestExpenseDebt
26079000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
34063000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
515937000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
350000000
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
900000000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2871000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5386000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
6355000
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
10177000
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
7154000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
6437000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
972000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4324000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
27.98
CY2020Q2 neog Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageGrantDateFairValue
6.98
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
403000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
34.23
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.71
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1389000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
24.38
CY2021 neog Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue
6.31
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
381000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
28.99
CY2021 neog Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue
7.20
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
643000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2957000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
27.98
CY2021Q2 neog Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageGrantDateFairValue
6.98
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
615000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
36.42
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.49
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
281000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
22.79
CY2022 neog Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue
6.29
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
47000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
33.93
CY2022 neog Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue
8.02
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1191000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3244000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
32.13
CY2022Q2 neog Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageGrantDateFairValue
7.66
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1704000
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.68
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.61
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
22000
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
14.78
CY2023 neog Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue
4.23
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
704000
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
29.81
CY2023 neog Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue
7.26
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1401000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4222000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
25.56
CY2023Q2 neog Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageGrantDateFairValue
6.51
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4222000
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y9M18D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
25.56
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1401000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
31.54
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
30.24
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
28.10
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
11729000
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y4M24D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6154000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
850000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
46667000
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
42000
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
817000
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
11617000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
73000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5507000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
22349000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.033
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.004
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.002
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.340
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.328
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.313
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6M
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y1M13D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y3M
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
121000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
34.21
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
169000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
37.28
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
25000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
34.24
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
8000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
36.80
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
257000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
36.14
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
596000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.83
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
60000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
35.14
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
27000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
22.81
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
766000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
19.30
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
34.21
CY2023 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
94604
CY2022 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
43456
CY2021 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
38406
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22042000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
60207000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
75268000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
8674000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
8579000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
6981000
CY2023 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
278000
CY2022 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
3000
CY2021 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
-75000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1616000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2406000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2147000
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
9490000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
5140000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
4875000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
20058000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
16128000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
13928000
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-17406000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3721000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
479000
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1865000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-356000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
44000
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
41000
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-151000
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-65000
CY2023 neog Deferred Federal State Local And Foreign Tax Expense Benefit
DeferredFederalStateLocalAndForeignTaxExpenseBenefit
-19230000
CY2022 neog Deferred Federal State Local And Foreign Tax Expense Benefit
DeferredFederalStateLocalAndForeignTaxExpenseBenefit
-4228000
CY2021 neog Deferred Federal State Local And Foreign Tax Expense Benefit
DeferredFederalStateLocalAndForeignTaxExpenseBenefit
458000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
828000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11900000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14386000
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4629000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
12643000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
15806000
CY2023 neog Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
325000
CY2022 neog Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
179000
CY2021 neog Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
292000
CY2023 neog Income Tax Reconciliation Global Intangiblelowtaxedincome Amount
IncomeTaxReconciliationGlobalIntangiblelowtaxedincomeAmount
6482000
CY2022 neog Income Tax Reconciliation Global Intangiblelowtaxedincome Amount
IncomeTaxReconciliationGlobalIntangiblelowtaxedincomeAmount
1501000
CY2021 neog Income Tax Reconciliation Global Intangiblelowtaxedincome Amount
IncomeTaxReconciliationGlobalIntangiblelowtaxedincomeAmount
2064000
CY2023 neog Income Tax Reconciliation Foreign Derived Intangible Income Deduction Amount
IncomeTaxReconciliationForeignDerivedIntangibleIncomeDeductionAmount
-643000
CY2022 neog Income Tax Reconciliation Foreign Derived Intangible Income Deduction Amount
IncomeTaxReconciliationForeignDerivedIntangibleIncomeDeductionAmount
-1308000
CY2021 neog Income Tax Reconciliation Foreign Derived Intangible Income Deduction Amount
IncomeTaxReconciliationForeignDerivedIntangibleIncomeDeductionAmount
-1210000
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-3742000
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
215000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
669000
CY2023 neog Income Tax Reconciliation Subpart F Income
IncomeTaxReconciliationSubpartFIncome
152000
CY2022 neog Income Tax Reconciliation Subpart F Income
IncomeTaxReconciliationSubpartFIncome
397000
CY2021 neog Income Tax Reconciliation Subpart F Income
IncomeTaxReconciliationSubpartFIncome
628000
CY2023 neog Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Expense Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitExpenseAmount
1946000
CY2022 neog Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Expense Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitExpenseAmount
-462000
CY2021 neog Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Expense Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitExpenseAmount
-2651000
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
18000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1517000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1601000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
7187000
CY2023 neog Income Tax Reconciliation Tax Credits And Other
IncomeTaxReconciliationTaxCreditsAndOther
-6709000
CY2022 neog Income Tax Reconciliation Tax Credits And Other
IncomeTaxReconciliationTaxCreditsAndOther
-2527000
CY2021 neog Income Tax Reconciliation Tax Credits And Other
IncomeTaxReconciliationTaxCreditsAndOther
-3298000
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
583000
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-75000
CY2023 neog Income Tax Reconciliation Tax Related Uncertainties
IncomeTaxReconciliationTaxRelatedUncertainties
278000
CY2022 neog Income Tax Reconciliation Tax Related Uncertainties
IncomeTaxReconciliationTaxRelatedUncertainties
3000
CY2021 neog Income Tax Reconciliation Tax Related Uncertainties
IncomeTaxReconciliationTaxRelatedUncertainties
55000
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
355000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
85000
CY2023 neog Income Tax Reconciliation Research Expenditures Deduction
IncomeTaxReconciliationResearchExpendituresDeduction
-365000
CY2022 neog Income Tax Reconciliation Research Expenditures Deduction
IncomeTaxReconciliationResearchExpendituresDeduction
-112000
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
173000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-814000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
505000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
828000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11900000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14386000
CY2023 us-gaap Income Tax Reconciliation Tax Credits Foreign
IncomeTaxReconciliationTaxCreditsForeign
5324000
CY2022 us-gaap Income Tax Reconciliation Tax Credits Foreign
IncomeTaxReconciliationTaxCreditsForeign
1747000
CY2021 us-gaap Income Tax Reconciliation Tax Credits Foreign
IncomeTaxReconciliationTaxCreditsForeign
2753000
CY2023 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1385000
CY2022 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
780000
CY2021 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
545000
CY2023Q2 neog Deferred Tax Liabilities Property Plant And Equipment And Intangible Assets
DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndIntangibleAssets
369500000
CY2022Q2 neog Deferred Tax Liabilities Property Plant And Equipment And Intangible Assets
DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndIntangibleAssets
22709000
CY2023Q2 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
1834000
CY2022Q2 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
344000
CY2023Q2 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
1480000
CY2022Q2 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
884000
CY2023Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
372814000
CY2022Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
23937000
CY2023Q2 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
5782000
CY2023Q2 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
5868000
CY2023Q2 neog Deferred Tax Assets Stock Options
DeferredTaxAssetsStockOptions
2192000
CY2022Q2 neog Deferred Tax Assets Stock Options
DeferredTaxAssetsStockOptions
2085000
CY2023Q2 neog Deferred Tax Assets Receivables And Inventories
DeferredTaxAssetsReceivablesAndInventories
3219000
CY2022Q2 neog Deferred Tax Assets Receivables And Inventories
DeferredTaxAssetsReceivablesAndInventories
2044000
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3909000
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
561000
CY2023Q2 neog Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
1899000
CY2022Q2 neog Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
382000
CY2023Q2 neog Deferred Tax Assets Accrued Liabilities And Other
DeferredTaxAssetsAccruedLiabilitiesAndOther
1981000
CY2022Q2 neog Deferred Tax Assets Accrued Liabilities And Other
DeferredTaxAssetsAccruedLiabilitiesAndOther
2422000
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
24850000
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
7494000
CY2023Q2 neog Deferred Tax Asset Valuation Allowance Loss Carry Forwards
DeferredTaxAssetValuationAllowanceLossCarryForwards
-2110000
CY2022Q2 neog Deferred Tax Asset Valuation Allowance Loss Carry Forwards
DeferredTaxAssetValuationAllowanceLossCarryForwards
-568000
CY2023Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
350074000
CY2022Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
17011000
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3353000
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
575000
CY2023Q2 neog Deferred Income Tax Liabilities Gross
DeferredIncomeTaxLiabilitiesGross
353427000
CY2022Q2 neog Deferred Income Tax Liabilities Gross
DeferredIncomeTaxLiabilitiesGross
17586000
CY2023Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
350074000
CY2022Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
17011000
CY2023Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
13580000
CY2023Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
145000
CY2022Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
69000
CY2021Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
65000
CY2023Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1087000
CY2022Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
808000
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
741000
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
764000
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
762000
CY2023 neog Unrecognized Tax Benefits Increase Decrease Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions
-2000
CY2022 neog Unrecognized Tax Benefits Increase Decrease Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions
-75000
CY2021 neog Unrecognized Tax Benefits Increase Decrease Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions
-182000
CY2023 neog Unrecognized Tax Benefits Increase Decrease Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromCurrentPeriodTaxPositions
479000
CY2022 neog Unrecognized Tax Benefits Increase Decrease Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromCurrentPeriodTaxPositions
147000
CY2021 neog Unrecognized Tax Benefits Increase Decrease Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromCurrentPeriodTaxPositions
184000
CY2023 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
276000
CY2022 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
95000
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
946000
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
741000
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
764000
CY2023Q2 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
153000000
CY2023 neog Undistributed Earnings Not Permanently Reinvested
UndistributedEarningsNotPermanentlyReinvested
41000000
CY2023Q2 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
112000000
CY2022Q2 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
916000
CY2023Q2 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
916000
CY2023 neog Accrual For Environmental Loss Contingencies Undiscounted Estimated Period
AccrualForEnvironmentalLossContingenciesUndiscountedEstimatedPeriod
P15Y
CY2023 neog Testing And Treatment Costs
TestingAndTreatmentCosts
85000
CY2023Q2 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
100000
CY2023Q2 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
816000
CY2023 us-gaap Accrual For Environmental Loss Contingencies Charges To Expense For New Losses
AccrualForEnvironmentalLossContingenciesChargesToExpenseForNewLosses
600000
CY2023Q2 us-gaap Loss Contingency Accrual Carrying Value Period Increase Decrease
LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
600000
CY2023 us-gaap Royalty Expense
RoyaltyExpense
3392000
CY2022 us-gaap Royalty Expense
RoyaltyExpense
1999000
CY2021 us-gaap Royalty Expense
RoyaltyExpense
2129000
CY2023Q2 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
112000
CY2023Q2 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
109000
CY2023Q2 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
84000
CY2023Q2 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
84000
CY2023Q2 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
67000
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
2439000
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1834000
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1204000
CY2023Q2 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
927720000
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
900000000
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
822447000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
37515000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
88377000
CY2023 us-gaap Interest Expense Other
InterestExpenseOther
55961000
CY2023Q2 us-gaap Assets
Assets
4554432000
CY2023 neog Expenditures For Long Lived Assets
ExpendituresForLongLivedAssets
65757000
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
527159000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
58618000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23694000
CY2022 us-gaap Interest Expense Other
InterestExpenseOther
72000
CY2022Q2 us-gaap Assets
Assets
992929000
CY2022 neog Expenditures For Long Lived Assets
ExpendituresForLongLivedAssets
24781000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
468459000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
74169000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21041000
CY2021 us-gaap Interest Expense Other
InterestExpenseOther
78000
CY2021Q2 us-gaap Assets
Assets
920192000
CY2021 neog Expenditures For Long Lived Assets
ExpendituresForLongLivedAssets
26712000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
822447000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
527159000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
468459000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
198749000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
110584000

Files In Submission

Name View Source Status
0000950170-23-042861-index-headers.html Edgar Link pending
0000950170-23-042861-index.html Edgar Link pending
0000950170-23-042861.txt Edgar Link pending
0000950170-23-042861-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
neog-20230531.htm Edgar Link pending
neog-20230531.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
neog-20230531_cal.xml Edgar Link unprocessable
neog-20230531_def.xml Edgar Link unprocessable
neog-20230531_htm.xml Edgar Link completed
neog-ex21.htm Edgar Link pending
neog-ex23.htm Edgar Link pending
neog-ex24.htm Edgar Link pending
neog-ex31_1.htm Edgar Link pending
neog-ex31_2.htm Edgar Link pending
neog-ex32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
neog-20230531_pre.xml Edgar Link unprocessable
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
neog-20230531_lab.xml Edgar Link unprocessable